Publications by authors named "Miranda Chakos"

Claim this Profile
S
Safe Use of Atypical Antipsychotics in a Patient With Postpartum Psychosis and a History of Seronegative Myasthenia Gravis.
Stuart Kyllo, Daniel McBride, Miranda Chakos

Prim Care Companion CNS Disord· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant psychotropic medication use during treatment of schizophrenia patients: longitudinal results from the CATIE study.
Miranda Chakos, Javendra K Patel, Robert Rosenheck, Ira D Glick, Mark B Hammer

Clin Schizophr Relat Psychoses· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.
Stanley N Caroff, Vicki G Davis, Del D Miller, Sonia M Davis, Robert A Rosenheck, Miranda H Chakos

J Clin Psychiatry· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extrapyramidal side-effects of antipsychotics in a randomised trial.
Del D Miller, Stanley N Caroff, Sonia M Davis, Robert A Rosenheck, Joseph P McEvoy, Miranda H Chakos

Br J Psychiatry· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder.
Matthew J Hoptman, Jan Volavka, Pál Czobor, Guido Gerig, Miranda Chakos

J Neuropsychiatry Clin Neurosci· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trial.
Miranda H Chakos, Ira D Glick, Alexander L Miller, Mark B Hamner, Del D Miller

Psychiatr Serv· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics.
Karen A Nolan, Pál Czobor, Leslie L Citrome, Menachem Krakowski, Herbert M Lachman, Miranda Chakos

J Clin Psychopharmacol· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.
Jonathan M Meyer, Henry A Nasrallah, Joseph P McEvoy, Donald C Goff, Sonia M Davis, Miranda Chakos

Schizophr Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
Del D Miller, Joseph P McEvoy, Sonia M Davis, Stanley N Caroff, Bruce L Saltz, Miranda H Chakos

Schizophr Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder.
Matthew J Hoptman, Jan Volavka, Elisabeth M Weiss, Pál Czobor, Philip R Szeszko, Miranda Chakos

Psychiatry Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of illness and treatment effects on hippocampal volume in male patients with schizophrenia.
Miranda H Chakos, Scott A Schobel, Hongbin Gu, Guido Gerig, Daniel Bradford

Br J Psychiatry· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects.
Rael D Strous, Jose M J Alvir, Delbert Robinson, Gilad Gal, Brian Sheitman, Miranda Chakos

Schizophr Bull· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.
Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A Lieberman, Leslie Citrome, Miranda Chakos

J Clin Psychiatry· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretin for refractory schizophrenia.
Brian B Sheitman, Michael B Knable, L Fredrik Jarskog, Miranda Chakos, Leslie H Boyce

Schizophr Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Leslie Citrome, Brian Sheitman, Miranda Chakos

Am J Psychiatry· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.
Robert M Bilder, Jan Volavka, Pál Czobor, Anil K Malhotra, James L Kennedy, Miranda Chakos

Biol Psychiatry· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
Jean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, Jeffrey A Lieberman, Leslie Citrome, Miranda Chakos

J Clin Psychiatry· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic-induced weight gain and therapeutic response: a differential association.
Pál Czobor, Jan Volavka, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Miranda Chakos

J Clin Psychopharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.
Robert M Bilder, Robert S Goldman, Jan Volavka, Pal Czobor, Matthew Hoptman, Miranda Chakos

Am J Psychiatry· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
Jan Volavka, Pal Czobor, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Miranda Chakos

Am J Psychiatry· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis